🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Randomised, double-blind clinical trial to test humoral and cellular immuno...
Status
Completed
Location
Rigshospitalet
Start Date
2019-04-15
Trial ID
NCT03780179
The purpose of the study is to compare the immunogenicity and safety of a b...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-01
Trial ID
NCT01245049
Treatments Being Tested
This study will evaluate the immunogenicity and safety of Beijing Tiantan's...
Status
Completed
Location
Hebei Provincial Center for Disease Control and Prevention
Start Date
2016-03
Trial ID
NCT03160820
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of c...
Status
Completed
Location
Hanbin District Center for Disease Control and Prevention
Start Date
2019-07-26
Trial ID
NCT04111432
This study will compare Measles, Mumps, Rubella, and Varicella Vaccine (V22...
Status
Completed
Location
Multiple Locations
Start Date
1998-03
Trial ID
NCT00975507
This study will collect data on the safety of the MMRV vaccine (Priorix-Tet...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01738841
Treatments Being Tested
This study is a Phase III, randomized, single-blind, placebo-controlled, mu...
Status
Terminated
Location
Alabama Clinical Therapeutics - Birmingham - St. Vincent's Drive- Site Number : 8400007
Start Date
2024-05-13
Trial ID
NCT06397768
Treatments Being Tested
The goal of this study is to determine whether a computer-based interventio...
Status
Completed
Location
UMHS Outpatient Pediatrics
Start Date
2011-06
Trial ID
NCT01369394
Treatments Being Tested
This study will test the safety and how well the body's immune system respo...
Status
Terminated
Location
Stanford University
Start Date
2005-10
Trial ID
NCT00258726
Eligible,healthy infants who have finished the 3-dose-schedule of sIPV+DTaP...
Status
Unknown
Location
Anhui Provincial Center for Disease Control and Prevention
Start Date
2020-11-13
Trial ID
NCT04638985
Treatments Being Tested